PERINDOPRIL/INDAPAMIDA VISO FARMACEUTICA 4 MG/1,25 MG COMPRIMIDOS EFG スペイン - スペイン語 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

perindopril/indapamida viso farmaceutica 4 mg/1,25 mg comprimidos efg

glenmark arzneimittel gmbh - perindopril erbumina; indapamida - comprimido - 4 mg/1,25 mg - perindopril erbumina 4 mg; indapamida 1,25 mg - perindopril y diuréticos

KETOCONAZOL 200 mg TABLETA ペルー - スペイン語 - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

ketoconazol 200 mg tableta

medrock corporation sociedad anonima cerrada - ketoconazol; - tableta - por tableta - ketoconazol

Cabometyx 欧州連合 - スペイン語 - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - agentes antineoplásicos - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Cometriq 欧州連合 - スペイン語 - EMA (European Medicines Agency)

cometriq

ipsen pharma - cabozantinib - neoplasias tiroideas - agentes antineoplásicos - tratamiento de pacientes adultos con carcinoma de tiroides medular localmente avanzado o metastásico progresivo e irresecable.

ITRACONAZOL TOSICINA 100 mg CAPSULAS DURAS EFG スペイン - スペイン語 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

itraconazol tosicina 100 mg capsulas duras efg

sandoz farmaceutica, s.a. - itraconazol - excipientes: azucar , esferas de,capsulas de gelatina dura - antimicÓticos para uso sistÉmico - derivados triazólicos - itraconazol

Tabrecta 欧州連合 - スペイン語 - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinoma, pulmón no microcítico - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

ONGLYZA 5 mg comprimido recubierto ウルグアイ - スペイン語 - Ministerio de Salud (Dirección Oficina Central)

onglyza 5 mg comprimido recubierto

astrazeneca (distribución exclusiva por gramón bagó de uruguay s.a.) - comprimido recubierto - saxagliptina 5 mg comprimido